nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—SLC22A1—Latanoprost—glaucoma	0.185	0.252	CbGbCtD
Ranitidine—SLC22A1—Clonidine—glaucoma	0.0684	0.0932	CbGbCtD
Ranitidine—CYP2D6—Carteolol—glaucoma	0.0534	0.0727	CbGbCtD
Ranitidine—CYP1A2—Betaxolol—glaucoma	0.0437	0.0596	CbGbCtD
Ranitidine—CYP2D6—Betaxolol—glaucoma	0.036	0.0491	CbGbCtD
Ranitidine—CYP2C19—Methazolamide—glaucoma	0.0359	0.0489	CbGbCtD
Ranitidine—CYP3A5—Clonidine—glaucoma	0.0322	0.0439	CbGbCtD
Ranitidine—CYP2C19—Timolol—glaucoma	0.0306	0.0416	CbGbCtD
Ranitidine—CYP2D6—Methazolamide—glaucoma	0.0273	0.0372	CbGbCtD
Ranitidine—CYP3A4—Pilocarpine—glaucoma	0.0257	0.035	CbGbCtD
Ranitidine—ABCB1—Timolol—glaucoma	0.0247	0.0336	CbGbCtD
Ranitidine—CYP1A2—Clonidine—glaucoma	0.024	0.0326	CbGbCtD
Ranitidine—CYP2D6—Timolol—glaucoma	0.0232	0.0316	CbGbCtD
Ranitidine—ABCB1—Clonidine—glaucoma	0.021	0.0285	CbGbCtD
Ranitidine—CYP3A4—Brinzolamide—glaucoma	0.0202	0.0275	CbGbCtD
Ranitidine—CYP2D6—Clonidine—glaucoma	0.0197	0.0269	CbGbCtD
Ranitidine—CYP3A4—Dorzolamide—glaucoma	0.0195	0.0265	CbGbCtD
Ranitidine—CYP3A4—Methazolamide—glaucoma	0.0174	0.0237	CbGbCtD
Ranitidine—CYP3A4—Acetazolamide—glaucoma	0.0139	0.0189	CbGbCtD
Ranitidine—CYP3A4—Clonidine—glaucoma	0.0126	0.0171	CbGbCtD
Ranitidine—Nausea—Diclofenamide—glaucoma	0.000386	0.00157	CcSEcCtD
Ranitidine—Discomfort—Brinzolamide—glaucoma	0.000385	0.00157	CcSEcCtD
Ranitidine—Pain—Bimatoprost—glaucoma	0.000384	0.00157	CcSEcCtD
Ranitidine—Dizziness—Latanoprost—glaucoma	0.000383	0.00156	CcSEcCtD
Ranitidine—Confusional state—Dorzolamide—glaucoma	0.000383	0.00156	CcSEcCtD
Ranitidine—Feeling abnormal—Apraclonidine—glaucoma	0.000382	0.00156	CcSEcCtD
Ranitidine—Vomiting—Methazolamide—glaucoma	0.000381	0.00155	CcSEcCtD
Ranitidine—Anaphylactic shock—Dorzolamide—glaucoma	0.00038	0.00155	CcSEcCtD
Ranitidine—Abdominal pain upper—Timolol—glaucoma	0.000379	0.00154	CcSEcCtD
Ranitidine—Rash—Methazolamide—glaucoma	0.000378	0.00154	CcSEcCtD
Ranitidine—Dermatitis—Methazolamide—glaucoma	0.000377	0.00154	CcSEcCtD
Ranitidine—Nausea—Carbachol—glaucoma	0.000377	0.00154	CcSEcCtD
Ranitidine—Sweating—Betaxolol—glaucoma	0.000375	0.00153	CcSEcCtD
Ranitidine—Headache—Methazolamide—glaucoma	0.000375	0.00153	CcSEcCtD
Ranitidine—Breast disorder—Timolol—glaucoma	0.000375	0.00153	CcSEcCtD
Ranitidine—Chest pain—Pilocarpine—glaucoma	0.000375	0.00153	CcSEcCtD
Ranitidine—Myalgia—Pilocarpine—glaucoma	0.000375	0.00153	CcSEcCtD
Ranitidine—Arthralgia—Pilocarpine—glaucoma	0.000375	0.00153	CcSEcCtD
Ranitidine—Hypotension—Brimonidine—glaucoma	0.000372	0.00152	CcSEcCtD
Ranitidine—Nausea—Levobunolol—glaucoma	0.000371	0.00151	CcSEcCtD
Ranitidine—Discomfort—Pilocarpine—glaucoma	0.00037	0.00151	CcSEcCtD
Ranitidine—Tachycardia—Travoprost—glaucoma	0.000369	0.0015	CcSEcCtD
Ranitidine—Somnolence—Acetazolamide—glaucoma	0.000369	0.0015	CcSEcCtD
Ranitidine—Hyperhidrosis—Dorzolamide—glaucoma	0.000367	0.0015	CcSEcCtD
Ranitidine—Abdominal pain—Apraclonidine—glaucoma	0.000366	0.00149	CcSEcCtD
Ranitidine—Rash—Latanoprost—glaucoma	0.000366	0.00149	CcSEcCtD
Ranitidine—Agranulocytosis—Betaxolol—glaucoma	0.000365	0.00149	CcSEcCtD
Ranitidine—Dermatitis—Latanoprost—glaucoma	0.000365	0.00149	CcSEcCtD
Ranitidine—Tachycardia—Brinzolamide—glaucoma	0.000365	0.00149	CcSEcCtD
Ranitidine—Headache—Latanoprost—glaucoma	0.000363	0.00148	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000363	0.00148	CcSEcCtD
Ranitidine—Confusional state—Pilocarpine—glaucoma	0.000362	0.00148	CcSEcCtD
Ranitidine—Arrhythmia—Clonidine—glaucoma	0.000361	0.00147	CcSEcCtD
Ranitidine—Insomnia—Brimonidine—glaucoma	0.00036	0.00147	CcSEcCtD
Ranitidine—Bradycardia—Betaxolol—glaucoma	0.000358	0.00146	CcSEcCtD
Ranitidine—Alopecia—Clonidine—glaucoma	0.000357	0.00145	CcSEcCtD
Ranitidine—Nausea—Methazolamide—glaucoma	0.000356	0.00145	CcSEcCtD
Ranitidine—Hypotension—Dorzolamide—glaucoma	0.000355	0.00145	CcSEcCtD
Ranitidine—Dyspnoea—Brimonidine—glaucoma	0.000355	0.00145	CcSEcCtD
Ranitidine—Somnolence—Brimonidine—glaucoma	0.000354	0.00144	CcSEcCtD
Ranitidine—Hypotension—Travoprost—glaucoma	0.000354	0.00144	CcSEcCtD
Ranitidine—Bronchospasm—Timolol—glaucoma	0.000353	0.00144	CcSEcCtD
Ranitidine—Thrombocytopenia—Pilocarpine—glaucoma	0.000352	0.00143	CcSEcCtD
Ranitidine—Erythema—Clonidine—glaucoma	0.000351	0.00143	CcSEcCtD
Ranitidine—Tachycardia—Pilocarpine—glaucoma	0.000351	0.00143	CcSEcCtD
Ranitidine—Hallucination—Betaxolol—glaucoma	0.00035	0.00142	CcSEcCtD
Ranitidine—Angina pectoris—Timolol—glaucoma	0.000349	0.00142	CcSEcCtD
Ranitidine—Hypotension—Brinzolamide—glaucoma	0.000349	0.00142	CcSEcCtD
Ranitidine—Hyperhidrosis—Pilocarpine—glaucoma	0.000347	0.00141	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000346	0.00141	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Travoprost—glaucoma	0.000345	0.0014	CcSEcCtD
Ranitidine—Insomnia—Dorzolamide—glaucoma	0.000344	0.0014	CcSEcCtD
Ranitidine—Feeling abnormal—Acetazolamide—glaucoma	0.000342	0.00139	CcSEcCtD
Ranitidine—Hypersensitivity—Apraclonidine—glaucoma	0.000342	0.00139	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.00034	0.00139	CcSEcCtD
Ranitidine—Pain—Brimonidine—glaucoma	0.00034	0.00139	CcSEcCtD
Ranitidine—Dyspnoea—Dorzolamide—glaucoma	0.000339	0.00138	CcSEcCtD
Ranitidine—Insomnia—Brinzolamide—glaucoma	0.000338	0.00138	CcSEcCtD
Ranitidine—Somnolence—Dorzolamide—glaucoma	0.000338	0.00138	CcSEcCtD
Ranitidine—Dyspnoea—Travoprost—glaucoma	0.000337	0.00137	CcSEcCtD
Ranitidine—Hypotension—Pilocarpine—glaucoma	0.000336	0.00137	CcSEcCtD
Ranitidine—Dyspnoea—Brinzolamide—glaucoma	0.000333	0.00136	CcSEcCtD
Ranitidine—Somnolence—Brinzolamide—glaucoma	0.000332	0.00135	CcSEcCtD
Ranitidine—Vision blurred—Clonidine—glaucoma	0.000331	0.00135	CcSEcCtD
Ranitidine—Erectile dysfunction—Timolol—glaucoma	0.00033	0.00135	CcSEcCtD
Ranitidine—Urticaria—Acetazolamide—glaucoma	0.000329	0.00134	CcSEcCtD
Ranitidine—Pruritus—Apraclonidine—glaucoma	0.000328	0.00134	CcSEcCtD
Ranitidine—Body temperature increased—Acetazolamide—glaucoma	0.000328	0.00134	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000327	0.00133	CcSEcCtD
Ranitidine—Ill-defined disorder—Clonidine—glaucoma	0.000326	0.00133	CcSEcCtD
Ranitidine—Pain—Dorzolamide—glaucoma	0.000325	0.00132	CcSEcCtD
Ranitidine—Insomnia—Pilocarpine—glaucoma	0.000325	0.00132	CcSEcCtD
Ranitidine—Weight decreased—Timolol—glaucoma	0.000325	0.00132	CcSEcCtD
Ranitidine—Constipation—Travoprost—glaucoma	0.000324	0.00132	CcSEcCtD
Ranitidine—Pain—Travoprost—glaucoma	0.000324	0.00132	CcSEcCtD
Ranitidine—Agitation—Clonidine—glaucoma	0.000323	0.00132	CcSEcCtD
Ranitidine—Angioedema—Clonidine—glaucoma	0.000321	0.00131	CcSEcCtD
Ranitidine—Dyspnoea—Pilocarpine—glaucoma	0.00032	0.0013	CcSEcCtD
Ranitidine—Pain—Brinzolamide—glaucoma	0.00032	0.0013	CcSEcCtD
Ranitidine—Somnolence—Pilocarpine—glaucoma	0.000319	0.0013	CcSEcCtD
Ranitidine—Pruritus—Bimatoprost—glaucoma	0.000318	0.0013	CcSEcCtD
Ranitidine—Diarrhoea—Apraclonidine—glaucoma	0.000317	0.00129	CcSEcCtD
Ranitidine—Malaise—Clonidine—glaucoma	0.000317	0.00129	CcSEcCtD
Ranitidine—Arrhythmia—Betaxolol—glaucoma	0.000314	0.00128	CcSEcCtD
Ranitidine—Feeling abnormal—Dorzolamide—glaucoma	0.000313	0.00128	CcSEcCtD
Ranitidine—Feeling abnormal—Travoprost—glaucoma	0.000312	0.00127	CcSEcCtD
Ranitidine—Alopecia—Betaxolol—glaucoma	0.000311	0.00127	CcSEcCtD
Ranitidine—Feeling abnormal—Brinzolamide—glaucoma	0.000308	0.00125	CcSEcCtD
Ranitidine—Constipation—Pilocarpine—glaucoma	0.000307	0.00125	CcSEcCtD
Ranitidine—Pain—Pilocarpine—glaucoma	0.000307	0.00125	CcSEcCtD
Ranitidine—Sweating—Timolol—glaucoma	0.000307	0.00125	CcSEcCtD
Ranitidine—Dizziness—Apraclonidine—glaucoma	0.000307	0.00125	CcSEcCtD
Ranitidine—Erythema—Betaxolol—glaucoma	0.000306	0.00125	CcSEcCtD
Ranitidine—Urticaria—Dorzolamide—glaucoma	0.000302	0.00123	CcSEcCtD
Ranitidine—Abdominal pain—Dorzolamide—glaucoma	0.0003	0.00122	CcSEcCtD
Ranitidine—Body temperature increased—Dorzolamide—glaucoma	0.0003	0.00122	CcSEcCtD
Ranitidine—Arthralgia—Clonidine—glaucoma	0.000299	0.00122	CcSEcCtD
Ranitidine—Chest pain—Clonidine—glaucoma	0.000299	0.00122	CcSEcCtD
Ranitidine—Abdominal pain—Travoprost—glaucoma	0.000299	0.00122	CcSEcCtD
Ranitidine—Agranulocytosis—Timolol—glaucoma	0.000298	0.00122	CcSEcCtD
Ranitidine—Dizziness—Bimatoprost—glaucoma	0.000297	0.00121	CcSEcCtD
Ranitidine—Urticaria—Brinzolamide—glaucoma	0.000297	0.00121	CcSEcCtD
Ranitidine—Feeling abnormal—Pilocarpine—glaucoma	0.000296	0.00121	CcSEcCtD
Ranitidine—Discomfort—Clonidine—glaucoma	0.000296	0.0012	CcSEcCtD
Ranitidine—Vomiting—Apraclonidine—glaucoma	0.000295	0.0012	CcSEcCtD
Ranitidine—Hypersensitivity—Brimonidine—glaucoma	0.000293	0.00119	CcSEcCtD
Ranitidine—Bradycardia—Timolol—glaucoma	0.000292	0.00119	CcSEcCtD
Ranitidine—Dermatitis—Apraclonidine—glaucoma	0.000292	0.00119	CcSEcCtD
Ranitidine—Headache—Apraclonidine—glaucoma	0.00029	0.00118	CcSEcCtD
Ranitidine—Confusional state—Clonidine—glaucoma	0.000289	0.00118	CcSEcCtD
Ranitidine—Vision blurred—Betaxolol—glaucoma	0.000288	0.00117	CcSEcCtD
Ranitidine—Hallucination—Timolol—glaucoma	0.000286	0.00116	CcSEcCtD
Ranitidine—Abdominal pain—Pilocarpine—glaucoma	0.000284	0.00116	CcSEcCtD
Ranitidine—Body temperature increased—Pilocarpine—glaucoma	0.000284	0.00116	CcSEcCtD
Ranitidine—Ill-defined disorder—Betaxolol—glaucoma	0.000284	0.00116	CcSEcCtD
Ranitidine—Diarrhoea—Acetazolamide—glaucoma	0.000284	0.00116	CcSEcCtD
Ranitidine—Rash—Bimatoprost—glaucoma	0.000283	0.00115	CcSEcCtD
Ranitidine—Dermatitis—Bimatoprost—glaucoma	0.000283	0.00115	CcSEcCtD
Ranitidine—Anaemia—Betaxolol—glaucoma	0.000283	0.00115	CcSEcCtD
Ranitidine—Pruritus—Brimonidine—glaucoma	0.000282	0.00115	CcSEcCtD
Ranitidine—Headache—Bimatoprost—glaucoma	0.000282	0.00115	CcSEcCtD
Ranitidine—Thrombocytopenia—Clonidine—glaucoma	0.000281	0.00114	CcSEcCtD
Ranitidine—Hypersensitivity—Dorzolamide—glaucoma	0.00028	0.00114	CcSEcCtD
Ranitidine—Tachycardia—Clonidine—glaucoma	0.00028	0.00114	CcSEcCtD
Ranitidine—Hypersensitivity—Travoprost—glaucoma	0.000279	0.00114	CcSEcCtD
Ranitidine—Hyperhidrosis—Clonidine—glaucoma	0.000277	0.00113	CcSEcCtD
Ranitidine—Malaise—Betaxolol—glaucoma	0.000276	0.00112	CcSEcCtD
Ranitidine—Nausea—Apraclonidine—glaucoma	0.000275	0.00112	CcSEcCtD
Ranitidine—Hypersensitivity—Brinzolamide—glaucoma	0.000275	0.00112	CcSEcCtD
Ranitidine—Vertigo—Betaxolol—glaucoma	0.000275	0.00112	CcSEcCtD
Ranitidine—Dizziness—Acetazolamide—glaucoma	0.000274	0.00112	CcSEcCtD
Ranitidine—Pruritus—Dorzolamide—glaucoma	0.000269	0.0011	CcSEcCtD
Ranitidine—Hypotension—Clonidine—glaucoma	0.000268	0.00109	CcSEcCtD
Ranitidine—Pruritus—Travoprost—glaucoma	0.000268	0.00109	CcSEcCtD
Ranitidine—Nausea—Bimatoprost—glaucoma	0.000267	0.00109	CcSEcCtD
Ranitidine—Hypersensitivity—Pilocarpine—glaucoma	0.000265	0.00108	CcSEcCtD
Ranitidine—Pruritus—Brinzolamide—glaucoma	0.000264	0.00108	CcSEcCtD
Ranitidine—Vomiting—Acetazolamide—glaucoma	0.000264	0.00107	CcSEcCtD
Ranitidine—Dizziness—Brimonidine—glaucoma	0.000263	0.00107	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000261	0.00106	CcSEcCtD
Ranitidine—Myalgia—Betaxolol—glaucoma	0.00026	0.00106	CcSEcCtD
Ranitidine—Chest pain—Betaxolol—glaucoma	0.00026	0.00106	CcSEcCtD
Ranitidine—Arthralgia—Betaxolol—glaucoma	0.00026	0.00106	CcSEcCtD
Ranitidine—Diarrhoea—Dorzolamide—glaucoma	0.00026	0.00106	CcSEcCtD
Ranitidine—Headache—Acetazolamide—glaucoma	0.00026	0.00106	CcSEcCtD
Ranitidine—Insomnia—Clonidine—glaucoma	0.000259	0.00106	CcSEcCtD
Ranitidine—Diarrhoea—Travoprost—glaucoma	0.000259	0.00105	CcSEcCtD
Ranitidine—Discomfort—Betaxolol—glaucoma	0.000257	0.00105	CcSEcCtD
Ranitidine—Arrhythmia—Timolol—glaucoma	0.000257	0.00105	CcSEcCtD
Ranitidine—Dyspnoea—Clonidine—glaucoma	0.000256	0.00104	CcSEcCtD
Ranitidine—Diarrhoea—Brinzolamide—glaucoma	0.000256	0.00104	CcSEcCtD
Ranitidine—Somnolence—Clonidine—glaucoma	0.000255	0.00104	CcSEcCtD
Ranitidine—Pruritus—Pilocarpine—glaucoma	0.000254	0.00104	CcSEcCtD
Ranitidine—Alopecia—Timolol—glaucoma	0.000254	0.00103	CcSEcCtD
Ranitidine—Confusional state—Betaxolol—glaucoma	0.000252	0.00103	CcSEcCtD
Ranitidine—Dizziness—Dorzolamide—glaucoma	0.000251	0.00102	CcSEcCtD
Ranitidine—Rash—Brimonidine—glaucoma	0.000251	0.00102	CcSEcCtD
Ranitidine—Dermatitis—Brimonidine—glaucoma	0.000251	0.00102	CcSEcCtD
Ranitidine—Dizziness—Travoprost—glaucoma	0.00025	0.00102	CcSEcCtD
Ranitidine—Erythema—Timolol—glaucoma	0.00025	0.00102	CcSEcCtD
Ranitidine—Headache—Brimonidine—glaucoma	0.000249	0.00102	CcSEcCtD
Ranitidine—Dizziness—Brinzolamide—glaucoma	0.000247	0.00101	CcSEcCtD
Ranitidine—Nausea—Acetazolamide—glaucoma	0.000246	0.001	CcSEcCtD
Ranitidine—Diarrhoea—Pilocarpine—glaucoma	0.000246	0.001	CcSEcCtD
Ranitidine—Pain—Clonidine—glaucoma	0.000245	0.000999	CcSEcCtD
Ranitidine—Constipation—Clonidine—glaucoma	0.000245	0.000999	CcSEcCtD
Ranitidine—Thrombocytopenia—Betaxolol—glaucoma	0.000244	0.000996	CcSEcCtD
Ranitidine—Tachycardia—Betaxolol—glaucoma	0.000244	0.000993	CcSEcCtD
Ranitidine—Vomiting—Dorzolamide—glaucoma	0.000242	0.000985	CcSEcCtD
Ranitidine—Hyperhidrosis—Betaxolol—glaucoma	0.000241	0.000983	CcSEcCtD
Ranitidine—Rash—Dorzolamide—glaucoma	0.00024	0.000976	CcSEcCtD
Ranitidine—Dermatitis—Dorzolamide—glaucoma	0.000239	0.000975	CcSEcCtD
Ranitidine—Rash—Travoprost—glaucoma	0.000239	0.000972	CcSEcCtD
Ranitidine—Dermatitis—Travoprost—glaucoma	0.000238	0.000971	CcSEcCtD
Ranitidine—Headache—Dorzolamide—glaucoma	0.000238	0.00097	CcSEcCtD
Ranitidine—Vomiting—Brinzolamide—glaucoma	0.000238	0.000968	CcSEcCtD
Ranitidine—Dizziness—Pilocarpine—glaucoma	0.000238	0.000968	CcSEcCtD
Ranitidine—Headache—Travoprost—glaucoma	0.000237	0.000966	CcSEcCtD
Ranitidine—Nausea—Brimonidine—glaucoma	0.000236	0.000963	CcSEcCtD
Ranitidine—Feeling abnormal—Clonidine—glaucoma	0.000236	0.000963	CcSEcCtD
Ranitidine—Rash—Brinzolamide—glaucoma	0.000236	0.00096	CcSEcCtD
Ranitidine—Vision blurred—Timolol—glaucoma	0.000236	0.00096	CcSEcCtD
Ranitidine—Dermatitis—Brinzolamide—glaucoma	0.000235	0.000959	CcSEcCtD
Ranitidine—Headache—Brinzolamide—glaucoma	0.000234	0.000954	CcSEcCtD
Ranitidine—Hypotension—Betaxolol—glaucoma	0.000233	0.000951	CcSEcCtD
Ranitidine—Angioedema—Timolol—glaucoma	0.000228	0.00093	CcSEcCtD
Ranitidine—Vomiting—Pilocarpine—glaucoma	0.000228	0.00093	CcSEcCtD
Ranitidine—Urticaria—Clonidine—glaucoma	0.000228	0.000928	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000228	0.000927	CcSEcCtD
Ranitidine—Body temperature increased—Clonidine—glaucoma	0.000227	0.000924	CcSEcCtD
Ranitidine—Abdominal pain—Clonidine—glaucoma	0.000227	0.000924	CcSEcCtD
Ranitidine—Rash—Pilocarpine—glaucoma	0.000226	0.000923	CcSEcCtD
Ranitidine—Dermatitis—Pilocarpine—glaucoma	0.000226	0.000922	CcSEcCtD
Ranitidine—Insomnia—Betaxolol—glaucoma	0.000226	0.00092	CcSEcCtD
Ranitidine—Nausea—Dorzolamide—glaucoma	0.000226	0.00092	CcSEcCtD
Ranitidine—Headache—Pilocarpine—glaucoma	0.000225	0.000917	CcSEcCtD
Ranitidine—Nausea—Travoprost—glaucoma	0.000225	0.000916	CcSEcCtD
Ranitidine—Vertigo—Timolol—glaucoma	0.000225	0.000915	CcSEcCtD
Ranitidine—Dyspnoea—Betaxolol—glaucoma	0.000223	0.000907	CcSEcCtD
Ranitidine—Nausea—Brinzolamide—glaucoma	0.000222	0.000904	CcSEcCtD
Ranitidine—Constipation—Betaxolol—glaucoma	0.000214	0.00087	CcSEcCtD
Ranitidine—Pain—Betaxolol—glaucoma	0.000214	0.00087	CcSEcCtD
Ranitidine—Nausea—Pilocarpine—glaucoma	0.000213	0.000869	CcSEcCtD
Ranitidine—Myalgia—Timolol—glaucoma	0.000213	0.000867	CcSEcCtD
Ranitidine—Chest pain—Timolol—glaucoma	0.000213	0.000867	CcSEcCtD
Ranitidine—Arthralgia—Timolol—glaucoma	0.000213	0.000867	CcSEcCtD
Ranitidine—Hypersensitivity—Clonidine—glaucoma	0.000211	0.000861	CcSEcCtD
Ranitidine—Discomfort—Timolol—glaucoma	0.00021	0.000857	CcSEcCtD
Ranitidine—Feeling abnormal—Betaxolol—glaucoma	0.000206	0.000838	CcSEcCtD
Ranitidine—Confusional state—Timolol—glaucoma	0.000206	0.000838	CcSEcCtD
Ranitidine—Anaphylactic shock—Timolol—glaucoma	0.000204	0.000831	CcSEcCtD
Ranitidine—Pruritus—Clonidine—glaucoma	0.000203	0.000827	CcSEcCtD
Ranitidine—Urticaria—Betaxolol—glaucoma	0.000198	0.000808	CcSEcCtD
Ranitidine—Body temperature increased—Betaxolol—glaucoma	0.000197	0.000804	CcSEcCtD
Ranitidine—Hyperhidrosis—Timolol—glaucoma	0.000197	0.000803	CcSEcCtD
Ranitidine—Diarrhoea—Clonidine—glaucoma	0.000196	0.0008	CcSEcCtD
Ranitidine—Hypotension—Timolol—glaucoma	0.000191	0.000777	CcSEcCtD
Ranitidine—Dizziness—Clonidine—glaucoma	0.00019	0.000773	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Timolol—glaucoma	0.000186	0.000757	CcSEcCtD
Ranitidine—Insomnia—Timolol—glaucoma	0.000185	0.000752	CcSEcCtD
Ranitidine—Hypersensitivity—Betaxolol—glaucoma	0.000184	0.00075	CcSEcCtD
Ranitidine—Vomiting—Clonidine—glaucoma	0.000182	0.000743	CcSEcCtD
Ranitidine—Dyspnoea—Timolol—glaucoma	0.000182	0.000741	CcSEcCtD
Ranitidine—Somnolence—Timolol—glaucoma	0.000181	0.000739	CcSEcCtD
Ranitidine—Rash—Clonidine—glaucoma	0.000181	0.000737	CcSEcCtD
Ranitidine—Dermatitis—Clonidine—glaucoma	0.000181	0.000736	CcSEcCtD
Ranitidine—Headache—Clonidine—glaucoma	0.00018	0.000732	CcSEcCtD
Ranitidine—Pruritus—Betaxolol—glaucoma	0.000177	0.00072	CcSEcCtD
Ranitidine—Pain—Timolol—glaucoma	0.000174	0.000711	CcSEcCtD
Ranitidine—Diarrhoea—Betaxolol—glaucoma	0.000171	0.000696	CcSEcCtD
Ranitidine—Nausea—Clonidine—glaucoma	0.00017	0.000694	CcSEcCtD
Ranitidine—Feeling abnormal—Timolol—glaucoma	0.000168	0.000685	CcSEcCtD
Ranitidine—Dizziness—Betaxolol—glaucoma	0.000165	0.000673	CcSEcCtD
Ranitidine—Urticaria—Timolol—glaucoma	0.000162	0.00066	CcSEcCtD
Ranitidine—Abdominal pain—Timolol—glaucoma	0.000161	0.000657	CcSEcCtD
Ranitidine—Body temperature increased—Timolol—glaucoma	0.000161	0.000657	CcSEcCtD
Ranitidine—Vomiting—Betaxolol—glaucoma	0.000159	0.000647	CcSEcCtD
Ranitidine—Rash—Betaxolol—glaucoma	0.000157	0.000641	CcSEcCtD
Ranitidine—Dermatitis—Betaxolol—glaucoma	0.000157	0.000641	CcSEcCtD
Ranitidine—Headache—Betaxolol—glaucoma	0.000156	0.000637	CcSEcCtD
Ranitidine—Hypersensitivity—Timolol—glaucoma	0.00015	0.000612	CcSEcCtD
Ranitidine—Nausea—Betaxolol—glaucoma	0.000148	0.000604	CcSEcCtD
Ranitidine—Pruritus—Timolol—glaucoma	0.000144	0.000588	CcSEcCtD
Ranitidine—Diarrhoea—Timolol—glaucoma	0.00014	0.000569	CcSEcCtD
Ranitidine—Dizziness—Timolol—glaucoma	0.000135	0.00055	CcSEcCtD
Ranitidine—Vomiting—Timolol—glaucoma	0.00013	0.000528	CcSEcCtD
Ranitidine—Rash—Timolol—glaucoma	0.000129	0.000524	CcSEcCtD
Ranitidine—Dermatitis—Timolol—glaucoma	0.000129	0.000524	CcSEcCtD
Ranitidine—Headache—Timolol—glaucoma	0.000128	0.000521	CcSEcCtD
Ranitidine—Nausea—Timolol—glaucoma	0.000121	0.000494	CcSEcCtD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000109	0.00538	CbGpPWpGaD
Ranitidine—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000108	0.00531	CbGpPWpGaD
Ranitidine—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000106	0.00522	CbGpPWpGaD
Ranitidine—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000105	0.00517	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000105	0.00517	CbGpPWpGaD
Ranitidine—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000103	0.00509	CbGpPWpGaD
Ranitidine—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	9.89e-05	0.00489	CbGpPWpGaD
Ranitidine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.58e-05	0.00473	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	9.28e-05	0.00458	CbGpPWpGaD
Ranitidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.14e-05	0.00451	CbGpPWpGaD
Ranitidine—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.02e-05	0.00445	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—OPN4—glaucoma	8.97e-05	0.00443	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	8.81e-05	0.00435	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	8.81e-05	0.00435	CbGpPWpGaD
Ranitidine—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	8.81e-05	0.00435	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—SLC6A13—glaucoma	8.77e-05	0.00433	CbGpPWpGaD
Ranitidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	8.66e-05	0.00428	CbGpPWpGaD
Ranitidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.4e-05	0.00415	CbGpPWpGaD
Ranitidine—SLC22A1—Transmission across Chemical Synapses—SLC6A1—glaucoma	8.38e-05	0.00414	CbGpPWpGaD
Ranitidine—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	8.38e-05	0.00414	CbGpPWpGaD
Ranitidine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.29e-05	0.0041	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	8.24e-05	0.00407	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—OPN4—glaucoma	8.14e-05	0.00402	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PTGFR—glaucoma	8.07e-05	0.00399	CbGpPWpGaD
Ranitidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.41e-05	0.00366	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PTGFR—glaucoma	7.33e-05	0.00362	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.27e-05	0.00359	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—SMO—glaucoma	7.2e-05	0.00356	CbGpPWpGaD
Ranitidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.12e-05	0.00352	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.07e-05	0.00349	CbGpPWpGaD
Ranitidine—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.03e-05	0.00347	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—LRP12—glaucoma	6.94e-05	0.00343	CbGpPWpGaD
Ranitidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.81e-05	0.00337	CbGpPWpGaD
Ranitidine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	6.8e-05	0.00336	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	6.79e-05	0.00336	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	6.68e-05	0.0033	CbGpPWpGaD
Ranitidine—CYP1A2—Phase II conjugation—GSTT1—glaucoma	6.58e-05	0.00325	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—SLC6A1—glaucoma	6.42e-05	0.00317	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—GSTT1—glaucoma	6.39e-05	0.00316	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	6.24e-05	0.00308	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	6.13e-05	0.00303	CbGpPWpGaD
Ranitidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.77e-05	0.00285	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CA5A—glaucoma	5.76e-05	0.00285	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NARFL—glaucoma	5.76e-05	0.00285	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL1A—glaucoma	5.75e-05	0.00284	CbGpPWpGaD
Ranitidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.5e-05	0.00271	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	5.45e-05	0.00269	CbGpPWpGaD
Ranitidine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.42e-05	0.00268	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.32e-05	0.00263	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—FAS—glaucoma	5.13e-05	0.00253	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—CYP1B1—glaucoma	5.09e-05	0.00251	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—C3—glaucoma	5.06e-05	0.0025	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	5.02e-05	0.00248	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—GSTT1—glaucoma	4.94e-05	0.00244	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—OPN4—glaucoma	4.81e-05	0.00238	CbGpPWpGaD
Ranitidine—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	4.77e-05	0.00235	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—EDN1—glaucoma	4.75e-05	0.00235	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.72e-05	0.00233	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—GSTT1—glaucoma	4.54e-05	0.00224	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CA5A—glaucoma	4.48e-05	0.00221	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NARFL—glaucoma	4.48e-05	0.00221	CbGpPWpGaD
Ranitidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	4.48e-05	0.00221	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HEYL—glaucoma	4.47e-05	0.00221	CbGpPWpGaD
Ranitidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.45e-05	0.0022	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	4.33e-05	0.00214	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTGFR—glaucoma	4.33e-05	0.00214	CbGpPWpGaD
Ranitidine—CYP1A2—Phase II conjugation—GSTM1—glaucoma	4.19e-05	0.00207	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—C3—glaucoma	4.15e-05	0.00205	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	4.14e-05	0.00205	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—GSTM1—glaucoma	4.07e-05	0.00201	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	4.01e-05	0.00198	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	3.97e-05	0.00196	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.94e-05	0.00194	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.88e-05	0.00192	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—GSTT1—glaucoma	3.85e-05	0.0019	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	3.76e-05	0.00186	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	3.76e-05	0.00186	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	3.71e-05	0.00183	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—SMO—glaucoma	3.7e-05	0.00183	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.68e-05	0.00182	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.62e-05	0.00179	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.57e-05	0.00176	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CA5A—glaucoma	3.46e-05	0.00171	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NARFL—glaucoma	3.46e-05	0.00171	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.45e-05	0.00171	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RPTOR—glaucoma	3.39e-05	0.00167	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NARFL—glaucoma	3.38e-05	0.00167	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CA5A—glaucoma	3.38e-05	0.00167	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NCK2—glaucoma	3.28e-05	0.00162	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	3.23e-05	0.0016	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CA5A—glaucoma	3.18e-05	0.00157	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NARFL—glaucoma	3.18e-05	0.00157	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—GSTM1—glaucoma	3.15e-05	0.00155	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.13e-05	0.00154	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	3.1e-05	0.00153	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.07e-05	0.00151	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.02e-05	0.00149	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.98e-05	0.00147	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.97e-05	0.00147	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.96e-05	0.00146	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.93e-05	0.00145	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.89e-05	0.00143	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.86e-05	0.00141	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.85e-05	0.00141	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CA1—glaucoma	2.81e-05	0.00139	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HDAC9—glaucoma	2.79e-05	0.00138	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.76e-05	0.00137	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CTSA—glaucoma	2.73e-05	0.00135	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NARFL—glaucoma	2.7e-05	0.00133	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CA5A—glaucoma	2.7e-05	0.00133	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—EDN1—glaucoma	2.68e-05	0.00133	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	2.68e-05	0.00132	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	2.68e-05	0.00132	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CA2—glaucoma	2.57e-05	0.00127	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.54e-05	0.00126	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.53e-05	0.00125	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—GSTM1—glaucoma	2.45e-05	0.00121	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EDN1—glaucoma	2.44e-05	0.0012	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	2.42e-05	0.00119	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.37e-05	0.00117	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—C3—glaucoma	2.34e-05	0.00116	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.33e-05	0.00115	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CA1—glaucoma	2.19e-05	0.00108	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SMO—glaucoma	2.18e-05	0.00108	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TNF—glaucoma	2.18e-05	0.00108	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.16e-05	0.00107	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—C3—glaucoma	2.13e-05	0.00105	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CTSA—glaucoma	2.12e-05	0.00105	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CA5A—glaucoma	2.08e-05	0.00103	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NARFL—glaucoma	2.08e-05	0.00103	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.02e-05	0.000999	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CA2—glaucoma	2e-05	0.000988	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NTRK2—glaucoma	2e-05	0.000986	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.89e-05	0.000934	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.87e-05	0.000922	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—TXN—glaucoma	1.81e-05	0.000896	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NGFR—glaucoma	1.71e-05	0.000846	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CA1—glaucoma	1.69e-05	0.000835	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CA1—glaucoma	1.65e-05	0.000815	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CTSA—glaucoma	1.64e-05	0.000809	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NTRK1—glaucoma	1.63e-05	0.000804	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CTSA—glaucoma	1.6e-05	0.000789	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.59e-05	0.000786	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CA1—glaucoma	1.55e-05	0.000768	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CA2—glaucoma	1.55e-05	0.000764	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.51e-05	0.000746	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.51e-05	0.000746	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CA2—glaucoma	1.51e-05	0.000745	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.51e-05	0.000745	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CTSA—glaucoma	1.51e-05	0.000744	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN2B—glaucoma	1.5e-05	0.000741	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EDN1—glaucoma	1.44e-05	0.000711	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CA2—glaucoma	1.42e-05	0.000702	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—TXN—glaucoma	1.41e-05	0.000696	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTT1—glaucoma	1.41e-05	0.000695	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NGF—glaucoma	1.32e-05	0.000653	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CA1—glaucoma	1.32e-05	0.000651	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CTSA—glaucoma	1.28e-05	0.00063	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—C3—glaucoma	1.26e-05	0.000621	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.25e-05	0.000619	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CA2—glaucoma	1.2e-05	0.000595	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.18e-05	0.000582	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.18e-05	0.000582	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—APOE—glaucoma	1.17e-05	0.000578	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CAV1—glaucoma	1.16e-05	0.000573	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ABCA1—glaucoma	1.12e-05	0.000554	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP1B1—glaucoma	1.12e-05	0.000554	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FN1—glaucoma	1.1e-05	0.000545	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTT1—glaucoma	1.09e-05	0.00054	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—BAD—glaucoma	1.09e-05	0.000539	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TXN—glaucoma	1.09e-05	0.000538	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.07e-05	0.000531	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TXN—glaucoma	1.06e-05	0.000525	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CA1—glaucoma	1.02e-05	0.000502	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TXN—glaucoma	1e-05	0.000495	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.94e-06	0.000491	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.85e-06	0.000486	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CTSA—glaucoma	9.84e-06	0.000486	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	9.47e-06	0.000468	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CA2—glaucoma	9.3e-06	0.000459	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTM1—glaucoma	8.96e-06	0.000443	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NOS3—glaucoma	8.77e-06	0.000433	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ABCA1—glaucoma	8.7e-06	0.00043	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP1B1—glaucoma	8.7e-06	0.00043	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TXN—glaucoma	8.49e-06	0.000419	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTT1—glaucoma	8.45e-06	0.000417	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTT1—glaucoma	8.24e-06	0.000407	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—MTHFR—glaucoma	7.92e-06	0.000391	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTT1—glaucoma	7.77e-06	0.000384	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.74e-06	0.000383	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.67e-06	0.000379	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN1B—glaucoma	7.6e-06	0.000375	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—APOE—glaucoma	7.37e-06	0.000364	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CAV1—glaucoma	7.3e-06	0.000361	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP9—glaucoma	7.04e-06	0.000348	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTM1—glaucoma	6.96e-06	0.000344	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.81e-06	0.000336	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ABCA1—glaucoma	6.73e-06	0.000332	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1B1—glaucoma	6.73e-06	0.000332	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTT1—glaucoma	6.58e-06	0.000325	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1B1—glaucoma	6.57e-06	0.000324	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ABCA1—glaucoma	6.57e-06	0.000324	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TXN—glaucoma	6.55e-06	0.000324	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—glaucoma	6.32e-06	0.000312	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ABCA1—glaucoma	6.19e-06	0.000306	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1B1—glaucoma	6.19e-06	0.000306	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—MTHFR—glaucoma	6.15e-06	0.000304	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—APOE—glaucoma	5.73e-06	0.000283	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CAV1—glaucoma	5.67e-06	0.00028	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NOS3—glaucoma	5.52e-06	0.000273	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTM1—glaucoma	5.38e-06	0.000266	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.31e-06	0.000262	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTM1—glaucoma	5.25e-06	0.000259	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ABCA1—glaucoma	5.24e-06	0.000259	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP1B1—glaucoma	5.24e-06	0.000259	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTT1—glaucoma	5.08e-06	0.000251	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—glaucoma	5.05e-06	0.000249	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTM1—glaucoma	4.95e-06	0.000244	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—glaucoma	4.77e-06	0.000236	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—MTHFR—glaucoma	4.75e-06	0.000235	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—MTHFR—glaucoma	4.64e-06	0.000229	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—APOE—glaucoma	4.43e-06	0.000219	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CAV1—glaucoma	4.39e-06	0.000217	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—MTHFR—glaucoma	4.37e-06	0.000216	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—APOE—glaucoma	4.32e-06	0.000213	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NOS3—glaucoma	4.29e-06	0.000212	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CAV1—glaucoma	4.28e-06	0.000211	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTM1—glaucoma	4.19e-06	0.000207	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—APOE—glaucoma	4.07e-06	0.000201	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1B1—glaucoma	4.05e-06	0.0002	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCA1—glaucoma	4.05e-06	0.0002	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CAV1—glaucoma	4.03e-06	0.000199	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—glaucoma	3.92e-06	0.000194	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTHFR—glaucoma	3.7e-06	0.000183	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—APOE—glaucoma	3.45e-06	0.00017	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CAV1—glaucoma	3.42e-06	0.000169	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NOS3—glaucoma	3.32e-06	0.000164	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NOS3—glaucoma	3.24e-06	0.00016	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTM1—glaucoma	3.24e-06	0.00016	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NOS3—glaucoma	3.05e-06	0.000151	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—glaucoma	3.03e-06	0.00015	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—glaucoma	2.96e-06	0.000146	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTHFR—glaucoma	2.86e-06	0.000141	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—glaucoma	2.79e-06	0.000138	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—APOE—glaucoma	2.66e-06	0.000131	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CAV1—glaucoma	2.64e-06	0.00013	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NOS3—glaucoma	2.58e-06	0.000128	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—glaucoma	2.36e-06	0.000117	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NOS3—glaucoma	1.99e-06	9.85e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—glaucoma	1.82e-06	9.01e-05	CbGpPWpGaD
